165 related articles for article (PubMed ID: 21477426)
1. Comprehensive report of olopatadine 0.6% nasal spray as treatment for children with seasonal allergic rhinitis.
Meltzer EO; Blaiss M; Fairchild CJ
Allergy Asthma Proc; 2011; 32(3):213-20. PubMed ID: 21477426
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis.
Berger WE; Ratner PH; Casale TB; Meltzer EO; Wall GM
Allergy Asthma Proc; 2009; 30(6):612-23. PubMed ID: 20031007
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study.
Yamamoto H; Yamada T; Kubo S; Osawa Y; Kimura Y; Oh M; Susuki D; Takabayashi T; Okamoto M; Fujieda S
Allergy Asthma Proc; 2010; 31(4):296-303. PubMed ID: 20819319
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis.
Meltzer EO; Hampel FC; Ratner PH; Bernstein DI; Larsen LV; Berger WE; Finn AF; Marple BF; Roland PS; Wall GM; Brubaker MJ; Dimas C; Potts SL; Silver LH; Barnes JR
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):600-6. PubMed ID: 16400902
[TBL] [Abstract][Full Text] [Related]
5. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
[TBL] [Abstract][Full Text] [Related]
6. Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis.
Kaliner MA; Storms W; Tilles S; Spector S; Tan R; LaForce C; Lanier BQ; Chipps B
Allergy Asthma Proc; 2009; 30(3):255-62. PubMed ID: 19549426
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
LaForce CF; Carr W; Tilles SA; Chipps BE; Storms W; Meltzer EO; Edwards M
Allergy Asthma Proc; 2010; 31(2):132-40. PubMed ID: 20302683
[TBL] [Abstract][Full Text] [Related]
8. Olopatadine nasal spray for the treatment of allergic rhinitis.
Roland PS; Marple BF; Wall GM
Expert Rev Clin Immunol; 2010 Mar; 6(2):197-204. PubMed ID: 20402382
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar.
Ratner PH; Hampel FC; Amar NJ; van Bavel JH; Mohar D; Marple BF; Roland PS; Wall GM; Brubaker MJ; Drake M; Turner D; Silver LH
Ann Allergy Asthma Immunol; 2005 Nov; 95(5):474-9. PubMed ID: 16312171
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive report of the efficacy, safety, quality of life, and work impact of Olopatadine 0.6% and Olopatadine 0.4% treatment in patients with seasonal allergic rhinitis.
Fairchild CJ; Meltzer EO; Roland PS; Wells D; Drake M; Wall GM
Allergy Asthma Proc; 2007; 28(6):716-23. PubMed ID: 18201438
[TBL] [Abstract][Full Text] [Related]
11. Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo.
Hampel FC; Ratner PH; Amar NJ; van Bavel JH; Mohar D; Fairchild CJ; Wall GM; Brubaker MJ; Drake M; Crenshaw KM
Allergy Asthma Proc; 2006; 27(3):202-7. PubMed ID: 16913262
[TBL] [Abstract][Full Text] [Related]
12. Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis.
Hampel FC; Pedinoff AJ; Jacobs RL; Caracta CF; Tantry SK
Allergy Asthma Proc; 2019 Jul; 40(4):261-272. PubMed ID: 31053180
[No Abstract] [Full Text] [Related]
13. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
Berger W; Meltzer EO; Amar N; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Bousquet J
Pediatr Allergy Immunol; 2016 Mar; 27(2):126-33. PubMed ID: 26928753
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis.
Gross GN; Berman G; Amar NJ; Caracta CF; Tantry SK
Ann Allergy Asthma Immunol; 2019 Jun; 122(6):630-638.e3. PubMed ID: 30910440
[TBL] [Abstract][Full Text] [Related]
15. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of twice-daily and once-daily olopatadine-mometasone combination nasal spray for seasonal allergic rhinitis.
Andrews CP; Mohar D; Salhi Y; Tantry SK
Ann Allergy Asthma Immunol; 2020 Feb; 124(2):171-178.e2. PubMed ID: 31734334
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of GSP301 nasal spray in children aged 6 to 11 years with seasonal allergic rhinitis.
Prenner BM; Amar NJ; Hampel FC; Caracta CF; Wu W
Ann Allergy Asthma Immunol; 2022 Nov; 129(5):618-626.e2. PubMed ID: 35926824
[TBL] [Abstract][Full Text] [Related]
18. Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate.
Patel D; Garadi R; Brubaker M; Conroy JP; Kaji Y; Crenshaw K; Whitling A; Wall GM
Allergy Asthma Proc; 2007; 28(5):592-9. PubMed ID: 18034980
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
Shah S; Berger W; Lumry W; La Force C; Wheeler W; Sacks H
Allergy Asthma Proc; 2009; 30(6):628-33. PubMed ID: 19930788
[TBL] [Abstract][Full Text] [Related]
20. Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older.
Roland PS; Ryan MW; Wall GM
Expert Opin Pharmacother; 2010 Jun; 11(9):1559-67. PubMed ID: 20482305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]